Author:
Weiermair Theresia,Svehlikova Eva,Magnes Christoph,Boulgaropoulos Beate,Altendorfer-Kroath Thomas,Hummer Joanna,Eberl Anita
Reference42 articles.
1. By the last point of analysis (indicated at 24 hours in Figure 2) all rats' 2-AG concentrations decreased by more than 64% with respect to the initial concentrations. Clinical study All measured data points lay above LLOQ for AEA and 2-AG. The measured concentrations ranged from 0;A trend of increased AEA concentration values pre-versus post-running was observed in all five participants
2. Druggable Targets in Endocannabinoid Signaling;A M Gregus;Adv Exp Med Biol,2020
3. Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions;A Tadijan;Antioxidants,2022
4. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus;F B�quet;Eur J Neurosci,2007